In vitro activity of newer β-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens
- 1 December 1983
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 1 (4) , 287-293
- https://doi.org/10.1016/0732-8893(83)90004-4
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporinsAntimicrobial Agents and Chemotherapy, 1982
- Comparative in vitro activities of beta-lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilliAntimicrobial Agents and Chemotherapy, 1982
- In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agentsAntimicrobial Agents and Chemotherapy, 1982
- Drugs Five Years LaterAnnals of Internal Medicine, 1981
- Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycinAntimicrobial Agents and Chemotherapy, 1980
- In vitro evaluation of cefoperazoneAntimicrobial Agents and Chemotherapy, 1980
- Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activitiesAntimicrobial Agents and Chemotherapy, 1979
- In Vitro Synergistic Effect of Netilmicin, a New Aminoglycoside AntibioticAntimicrobial Agents and Chemotherapy, 1976
- GENTAMICIN-RESISTANT PSEUDOMONAS ÆRUGINOSA AND SERRATIA MARCESCENS IN A GENERAL HOSPITALThe Lancet, 1976
- Effect of the Concentrations of Magnesium and Calcium on the In-Vitro Susceptibility of Pseudomonas aeruginosa to GentamicinThe Journal of Infectious Diseases, 1971